glp-1 obesity drug news today oct 2025 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response How Supply and Demand for

Description

Below are general points to consider for each FDA-approved use

If you have any questions in the meantime, don't hesitate to reach out

These results from longer trials with tirzepatide have elevated the performance standard for drug therapy directed at T2D and obesity

A recent meta-analysis involving 32,884 patients from 19 randomized controlled trials further confirmed a 23% reduction in all-cause mortality associated with GLP-1RAs use (OR = 0.77) (Rivera et al., 2024)

The medication is technically only FDA approved to treat Type 2 diabetes, but its so effective at reducing body weight that healthcare providers often prescribe it off-label as a weight loss medication